Increased urinary excretion of 2-hydroxyestrone but not 16α- hydroxyestrone in premenopausal women during a soya diet containing isoflavones

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1299-1305

  Lu, Lee Jane W ^a   Cree, Melanie ^a   Josyula, Shylaja ^a   Nagamani, Manubai ^b   Grady, James J ^a   Anderson, Karl E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; DAIDZEIN; ESTRADIOL; ESTROGEN DERIVATIVE; GENISTEIN; ISOFLAVONE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; FEMALE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; SOYBEAN; URINARY EXCRETION;

ADULT; BREAST NEOPLASMS; DIET; FEMALE; HUMANS; HYDROXYESTRONES; ISOFLAVONES; NEOPLASMS, HORMONE-DEPENDENT; PREMENOPAUSE; SOYBEANS;

EID: 0011714009     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Parkin, D. M. Cancers of the breast, endometrium and ovary: geographic correlations. Eur. J. Cancer Clin. Oncol., 25: 1917-1925, 1989.
2. Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-Ross, P. L., Rosenthal, J. F., and Hyer, M. B. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst., 85: 1819-1827, 1993.
3. Kolonel, L. W., Hankin, J. H., and Nomura, A. M. Multiethnic studies of diet, nutrition and cancer in Hawaii. Princess Takamatsu Symposia. 16: 29-40, 1985.
4. Barnes, S. Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med., 217: 386-392, 1998.
5. Severson, R. K., Nomura, A. M. Y., Grove, J., S., and Stemmermann, G. N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res., 49: 1857-1860, 1989.
6. Nomura, A. M., and Kolonel, L. N. Prostate cancer: a current perspective. Am. J. Epidemiol., 13: 200-227, 1991.
7. Lee, H. P., Gourley, L., Duffy, S. W., Esteve, J., Lee. I., and Day, N. E. Dietary effects on breast cancer risk in Singapore. Lancet, 337: 1197-1200, 1991.
8. Lee, H. P., Gourley, L., Duffy, S. W., Esteve, J., Lee, J., and Day, N. E. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control, 3: 313-322, 1992.
9. Hirose, K., Tajima, K., Hamajima, N., Inoue, M., Takezaki, T., Kuroishi, T., Yoshida, M., and Tokudome, S. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn. J. Cancer Res., 86: 146-154, 1995.
10. Wu, A. H., Ziegler, R. G., Horn-Ross, P. L., Nomura, A. M., West, D. W., Kolonel, L. N., Rosenthal, J. F., Hoover, R. N., and Pike, M. C. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomark. Prev., 5: 901-906, 1996.
11. Ingram, D., Sanders, K., Kolybaba, M., and Lopez, D. Case-control study of phytooestrogens and breast cancer. Lancet, 350: 990-994, 1997.
12. Goodman, M. T., Wilkens, L. R., Hankin, J. H., Lyu, L. C., Wu, A. H., and Kolonel, L. N. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol., 146: 294-306, 1997.
13. Zheng, W., Dai, Q., Custer, L. J., Shu, X. O., Wen, W. Q., Jin, F., and Franke, A. A. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol. Biomark. Prev., 8: 35-40, 1999.
14. Messina, M., and Barnes, S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst., 83: 541-546, 1991.
15. Adlercreutz, H., Markkanen, H., and Watanabe, S. Plasma concentrations of phytooestrogens in Japanese men. Lancet, 342: 1209-1210, 1993.
16. Seow, A., Shi, C. Y., Franke, A. A., Hankin, J. H., Lee, H. P., and Yu, M. C. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol. Biomark. Prev, 7: 135-140, 1998.
17. Maskarinec, G., Singh, S., Meng, L., and Franke, A. A. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol. Biornark. Prev., 7: 613-619, 1998.
18. Bernstein, L., Yuan, J. M., Ross, R. K., Pike, M. C., Hanisch, R., Lobo, R., Stanczyk, F., Gao, Y. T., and Henderson, B. E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angles: results from two breast cancer case-control studies. Cancer Causes Control. 1: 51-58, 1990.
19. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
20. Hankinson, S. E., Colditz, G. A., Hunter, D. J., Manson, J. E., Willett, W. C., Stampfer, M. J., Longcope, C., and Speizer, F. E. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control. 6: 217-224, 1995.
21. Toniolo, P. G. Endogenous estrogens and breast cancer risk - the case for prospective cohort studies. Environ. Health Perspect., 105: 587-592, 1997.
22. Wilcox, G., Wahlqvist, M. L., Burger, H. G., and Medley, G. Oestrogenic effects of plant foods in postmenopausal women. Br. Med. J., 301: 905-906, 1990.
23. Cassidy, A., Bingbam, S., and Setchell, K. D. R. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60: 333-340, 1994.
24. Cassidy, A., Bingham, S., and Setchell, K. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br. J. Nutr., 74: 587-601, 1995.
25. Baird, D. D., Umbach, D. M., Lansdell, L., Hughes, C. L., Setchell, K. D., Weinberg, C. R., Haney, A. F., Wilcox, A. J., and Mclachlan, J. A. Dietary intervention study to assess estrogenicity of dietary soya among postmenopausal women. J. Clin. Endocrinol. Metab., 80: 1685-1690, 1995.
26. Lu, L. J. W., Anderson, K. E., Grady, J. J., and Nagamani, M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol. Biomark. Prev., 5: 6.3-70, 1996.
27. Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., Lee, M. M., Miike, R., Kirk, M., and Coward, L. Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol. Biomark. Prev., 5: 785-794, 1996.
28. Brzezinski, A., Adlercreutz, H., Shaoul, R., Rosier, A., Shmueli, A., Tanos, V., and Schenker, J. G. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause, 4: 89-94, 1997.
29. Duncan, A. M., Merz, B. E., Xu, X., Nagel, T. C., Phipps, W. R., and Kurzer, M. S. Soy isoflavones exert modest hormonal effects in premenopausal women. J. Clin. Endocrinol. Metab., 84: 192-197, 1999.
30. Xu, X., Dlincan, A.M., Merz, B. E., and Kurzer, M. S. Effects of soy isoflavones on eslrogen and phytoestrogen metabolism in premenopausal women. Cancer Epideraiol. Biomark. Prev., 7: 1101-1108, 1998.
31. Nagata, C., Takatsuka, N., Inaha, S., Kawakami, N., and Shimizu, H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J. Natl. Cancer Inst., 90: 1830-1835, 1998.
32. Lu, L. J. W., Anderson, K. E., Grady, J. J., and Nagamani, M. Reduction of ovarian steroid hormone levels in premenopausal women with a soya supplemented diet. Proc. Am. Assoc. Cancer Res., 38: 209, 1997.
33. Lu, L. J. W., Anderson, K. E., Grady, J. J., and Nagamani, M. Gonadotropin levels in premenopausal women after soya consumption. Proc. Am. Assoc. Cancer Res., 39: 388, 1998.
34. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., Bradlow, H. L., and Fishman, J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA, 79: 3047-3051, 1982.
35. Fishman, J., and Martucci, C. Biological properties of 16α-hydroxyestrone: implications in estrogen physiology and pathophysiology. J. Clin. Endocrinol. Metab., 51: 611-615, 1980.
36. Osborne, M. P., Bradlow, H. L., Wong, G. Y., and Telang, N. T. Lip-regulation of estradiol C16 α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Inst., 85: 1917-1920, 1993.
37. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996
38. Zhu, B. T., and Conney, A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond.), 19: 1-27, 1998.
39. Zhu, B. T., and Conney, A. H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res., 58: 2269-2277, 1998.
40. Li, J. J., and Li, S. A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46: 1858-1863, 1987.
41. Liehr, J. G., and Roy, D. Free radical generation by redox cycling of estrogens. Free Radic. Biol. Med., 8: 415-423, 1990.
42. Martucci, C. P., and Fishman, J. P450 enzymes of estrogen metabolism. Pharmacol. Ther., 57: 237-257, 1993.
43. Telang, N. T., Suto, A., Wong, G. Y., Osborne, M. P., and Bradlow, H. L. Induction by estrogen metabolite 16 α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl. Cancer Inst., 84: 634-638, 1992.
44. Bradlow, H. L., Telang, N. T., Sepkovic, D. W., and Osborne, M. P. 2-Hydroxyestrone: the 'good'estrogen. J. Endocrinol., 150 (Suppl.): S259-S265, 1996.
45. Kabat, G. C., Chang, C. J., Sparano, J. A., Sepkovic, D. W., Hu, X. P., Khalil, A., Rosenblatt, R., and Bradlow, H. L. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomark. Prev., 6: 505-509, 1997.
46. Zheng, W., Dunning, L., Jin, F., and Holtzman, J. Correspondence re: G. C. Kabat, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomark. Prev., 6: 505-509, 1997 [letter; comment]. Cancer Epidemiol Biomark. Prev., 7: 85-86, 1998.
47. Zheng, W., Dunning, L., Jin, F., and Holtzman, J. Correspondence re: G. C. Kabat, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomark. Prev., 6: 505-509, 1997 [letter; comment]. Cancer Epidemiol Biomark. Prev., 7: 85-86, 1998.
48. Taioli, E., Garte, S. J., Trachman, J., Garbers, S., Sepkovic, D. W., Osborne, M. P., Mehl, S., and Bradlow, H. L. Ethnic differences in estrogen metabolism in healthy women [see comments]. J. Natl. Cancer Inst., 88: 617, 1996.
49. Coker, A. L., Crane, M. M., Sticca, R. P., and Sepkovic, D. W. Re: Ethnic differences in estrogen metabolism in healthy women [letter: comment). J. Natl. Cancer Inst., 89: 89-90, 1997.
50. Ho, G. H., Luo, X. W., Ji, C. Y., Foo, S. C., and Ng, E. H. Urinary 2/16 α-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann. Acad. Med. Singap., 27: 294-299, 1998.
51. Adlercreutz, H., Fotsis, T., Hockerstedt, K., Hamalainen, E., Bannwart, C., Bloigu, S., Valtonen, A., and Ollus, A. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J. Steroid Biochem, 34: 527-530, 1989.
52. Lemon, H. M., Heidel, J. W., and Rodriquez-Sierra, J. F. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer (Phila.), 69: 457-465, 1992.
53. Ursin, G., London, S., Stanczyk, F. Z., Gentzschein, E., Paganini-Hill, A., Ross, R. K., and Pike, M. C. Urinary 2-hydroxyeslrone/16 α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 91: 1067-1072, 1999.
54. De Cree, C., Van Kranenburg, G., Geunen, P., Fujimori, Y., and Keizer, H. A. 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil. Steril., 67: 505-516, 1997.
55. Frisch, R. E., Wyshak, G., Albright, N. L., Albright, T. E., Schiff, I., and Witschi, J. Former athletes have a lower lifetime occurrence of breast cancer and cancers of the reproductive system. Adv. Exp. Med. Biol., 322: 29-39, 1992.
56. Meilahn, E. N., De Stavola, B., Allen, D. S., Fentiman, I., Bradlow, H. L., Sepkovic, D. W., and Kuller, L. H. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br. J. Cancer, 78: 1250-1255, 1998.
57. Anderson, K. E., Kappas, A., Conney, A. H., Bradlow, H. L., and Fishman, J. The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. J. Clin. Endocrinol. Metab., 59: 103-107, 1984.
58. Bradlow, H. L., Michnovicz, J. J., Halper, M., Miller, D. G., Wong, G. Y., and Osborne, M. P., Long-term responses of women to indole-3-carhinol or a high fiber diet. Cancer Epidemiol. Biomark. Prev., J: 591-595, 1994.
59. Michnovicz, J. J., Adlercreutz, H., and Bradlow, H. L. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J. Natl. Cancer Inst., 89: 718-723, 1997.
60. Michnovicz, J. J. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int. J. Obes. Relat. Metab. Disord., 22: 227-229, 1998.
61. Harris, J. A., and Bennedict F. G. A Biometric Study of Basal Metabolism in Man, The Carnegie Institution of Washington Publication, No. 279. Washington DC: J. B. Lippincott Co., 1919.
62. Blackburn, G. L., Bistrian, B. R., Maini, B. S., Schlamm, H. T., and Smith, M. F. Nutritional and metabolic assessment of the hospitalized patient. J. Parenter. Enteral. Nutr., 1: 11-22, 1977.
63. McDowell, M. A., Briefel, R. R., Alaimo, K., Bischof, A. M., Caughman, C. R., Carrall, M. D., Loria, C. M., and Johnson, C. L. Energy and macronutrient intakes of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey. Phase I, 1988-1991. Advance data from initial and health statistics; No. 255. Hyattsville, MD: National Center for Health Statistics, 1994.
64. Lu, L. J. W., Broemeling, L. D., Marshall, M. V., and Sadagopa Ramanujam, V. M. A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol. Biomark. Prev., 4: 497-503, 1995.
65. Wang, C., Ma, Q., Pagadala, S., Sherrard, M. S., and Krishnan, P. G. Changes of isoflavones during processing of soy protein isolates. J. Am. Oil Chem. Soc., 75: 337-341, 1998.
66. Wang, H-J., and Murphy, P. A. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J. Agric. Food Chem., 42: 1674-1677, 1994.
67. McIntosh, J. A., Matthews, C. D., Cracker, J. M., Broom, T. J., and Cox, L. W. Predicting the luteinizing hormone surge: relationship between the duration of the follicular and luteal phases and the length of the human menstrual cycle. Fertil. Steril., 34: 125-130, 1980.
68. Aksel, S. Hormonal characteristics of long cycles in fertile women. Fertil. Steril, 36: 521-523, 1981.
69. Goebelsmann, U., and Mishell, D. R. The menstrual cycle. In: D. R. Mishell, and V. Davajan (eds.), Reproductive Endocrinology, Infertility and Contraception, pp. 67-89. Philadelphia: F. A. Davis Co., 1979.
70. Makela, S., Poutanen, M., Kostlan, M. L., Lehtimaki, N., Strauss, L., Santti, R., and Vihko, R. Inhibition of 17-β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc. Soc. Exp. Biol. Med., 217: 310-316, 1998.
71. Kao, Y. C., Zhou, C. B., Sherman, M., Laughton, C. A., and Chen, S. Molecular basis of the inhibition of human aromatase (estrogen synthetase ) by flavone and isoflavone phytoestrogens-a site-directed mutagenesis study. Environ. Health Perspect., 106: 85-92, 1998.
72. Spink, D. C., Spink, B. C., Cao, J. Q., DePasquale, J. A., Pentecost, B. T., Fasco, M. J., Li, and Suiter, T. R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis (Lond.), 19: 291-298, 1998.
73. Shou, M., Korzekwa, K. R., Brooks, E. N., Krausz, K. W., Gonzalez, F. I., and Gelboin, H. V. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis (Lond.), 18: 207-214, 1997.
74. Helsby, N. A., Chipman, J. K., Gescher, A., and Kerr, D. Inhibition of mouse and human CYP 1A-and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem. Toxicol. 36: 375-382, 1998.
75. Helsby, N. A., Williams, J., Kerr, D., Gescher, A., and Chipman, J. K. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica, 27: 587-596, 1997.
76. Swaneck, G. E., and Fishman, J. Covalent binding of the endogenous estrogen 16 α-hydroxyeslrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA, 85: 7831-7835, 1988.
77. Liehr, J. G. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney Carcinogenesis in hamsters. Environ. Health Perspect., 105 (Suppl. 3): 565-569, 1997.
78. Schneider, J., Huh, M. M., Bradlow, H. L., and Fishman, J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259: 4840-4845, 1984.
79. Vandewalle, B., and Lefebvre, J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol. Cell. Endocrinol., 67: 239-246, 1989.
80. Klauber, N., Parangi, S., Flynn, E., Hamel, E., and D'Amato, R. J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxycstradiol and taxol. Cancer Res., 57: 81-86, 1997.
81. Chen, Z., Zheng, W., Custer, L. J., Dai, Q., Shu, X. O., Jin, F., and Franke, A. A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer (Phila.), 33: 82-87, 1999.
82. Wakai, K., Egarai, I., Kato, K., Kawamura, T., Tamakoshi, A., Lin, Y. S., Nakayama, T., Wada, M., and Ohno, Y. Dietary intake and sources of isoflavones among Japanese. Nutr. Cancer (Phila.), 33: 139-145, 1999.